Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells

被引:28
作者
Yamada, K
Umegaki, H
Maezawa, I
Iguchi, A
Kameyama, T
Nabeshima, T
机构
[1] NAGOYA UNIV, SCH MED, DEPT NEUROPSYCHOPHARMACOL & HOSP PHARM, SHOWA KU, NAGOYA, AICHI 466, JAPAN
[2] NAGOYA UNIV, SCH MED, DEPT GERIATR, SHOWA KU, NAGOYA, AICHI 466, JAPAN
[3] MEIJO UNIV, FAC PHARMACEUT SCI, DEPT CHEM PHARMACOL, NAGOYA, AICHI 468, JAPAN
关键词
cytokine; NGF; neurotoxicity; catalase; free radicals;
D O I
10.1016/S0361-9230(96)00336-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the effects of various neurotrophic factors and cytokines on 6-hydroxydopamine (6-OHDA)-induced toxicity in PC12 cells. Exposure of PC12 cells to 6-OHDA resulted in a concentration- and time-dependent cell death, as evidenced by the release of lactate dehydrogenase into the culture medium. Addition of catalase, but not superoxide dismutase, to the culture medium protected PC12 cells from the 6-OHDA-induced toxicity. Interleukin (IL)-6 provided a dose-dependent protection against the 6-OHDA toxicity, as did nerve growth factor (NGF). In addition, basic fibroblast growth factor and dibutyryl cyclic AMP partially protected PC12 cells from 6-OHDA toxicity. Neither IL-1 alpha, IL-2, IL-4, transforming growth factor-beta, nor leukemia inhibitory factor had any effect. The protective effect of IL-6 was attenuated by 3-amino-1,2,4-triazole, an inhibitor of catalase. These results suggest that IL-6 may protect PC12 cells against the 6-OHDA toxicity by activating free radical detoxifying mechanisms, such as catalase activity. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:573 / 577
页数:5
相关论文
共 29 条
[1]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[2]   TROPHIC EFFECTS OF INTERLEUKIN-4, INTERLEUKIN-7 AND INTERLEUKIN-8 ON HIPPOCAMPAL NEURONAL CULTURES - POTENTIAL INVOLVEMENT OF GLIAL-DERIVED FACTORS [J].
ARAUJO, DM ;
COTMAN, CW .
BRAIN RESEARCH, 1993, 600 (01) :49-55
[3]   INTERLEUKIN-6 AND ALPHA-2-MACROGLOBULIN INDICATE AN ACUTE-PHASE STATE IN ALZHEIMERS-DISEASE CORTICES [J].
BAUER, J ;
STRAUSS, S ;
SCHREITERGASSER, U ;
GANTER, U ;
SCHLEGEL, P ;
WITT, I ;
YOLK, B ;
BERGER, M .
FEBS LETTERS, 1991, 285 (01) :111-114
[4]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[5]   CYTOKINE REGULATION OF NEURONAL SURVIVAL [J].
BRENNEMAN, DE ;
SCHULTZBERG, M ;
BARTFAI, T ;
GOZES, I .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :454-460
[6]  
DEMONTELLANO PRO, 1983, J BIOL CHEM, V258, P558
[7]   IL-1 and anti-inflammatory drugs modulate A beta cytotoxicity in PC12 cells [J].
Fagarasan, MO ;
Aisen, PS .
BRAIN RESEARCH, 1996, 723 (1-2) :231-234
[8]  
GIULIAN D, 1988, J NEUROSCI, V8, P709
[9]   INTERLEUKIN-6 IMPROVES THE SURVIVAL OF MESENCEPHALIC CATECHOLAMINERGIC AND SEPTAL CHOLINERGIC NEURONS FROM POSTNATAL, 2-WEEK-OLD RATS IN CULTURES [J].
HAMA, T ;
KUSHIMA, Y ;
MIYAMOTO, M ;
KUBOTA, M ;
TAKEI, N ;
HATANAKA, H .
NEUROSCIENCE, 1991, 40 (02) :445-452
[10]   INTERLEUKIN-6 AS A NEUROTROPHIC FACTOR FOR PROMOTING THE SURVIVAL OF CULTURED BASAL FOREBRAIN CHOLINERGIC NEURONS FROM POSTNATAL RATS [J].
HAMA, T ;
MIYAMOTO, M ;
TSUKUI, H ;
NISHIO, C ;
HATANAKA, H .
NEUROSCIENCE LETTERS, 1989, 104 (03) :340-344